Andrographolide and pterostilbene inhibit adipocyte differentiation by downregulating PPARγ through different...

Area of Science:

• Biochemistry
• Molecular Biology
• Cell Biology

Background:

• Adipogenesis is the process of stem cell differentiation into adipocytes, regulated by hormones and nutrients.
• Natural compounds are explored for anti-adipogenic effects via apoptosis, blocked differentiation, or inhibited triglyceride synthesis.
• Understanding the molecular mechanisms of these compounds is crucial for developing anti-obesity strategies.

Purpose of the Study:

• To elucidate the molecular mechanisms of andrographolide (AN) and pterostilbene (PT) in inhibiting human mesenchymal stem cell (MSC) differentiation into adipocytes.
• To investigate the role of AN and PT in regulating key adipogenic transcription factors and signaling pathways.

Main Methods:

• Human MSCs were induced to differentiate into adipocytes.
• The expression levels of microRNAs (e.g., miR27a) and proteins (e.g., SIRT1, PPARγ, SREBP1c) were analyzed.
• Reactive oxygen species (ROS) production during differentiation was measured.

Main Results:

• Andrographolide (AN) upregulated miR27a, while pterostilbene (PT) upregulated SIRT1.
• Both AN and PT inhibited the expression of key adipogenic transcription factors, including PPARγ (peroxisome proliferator-activated receptor gamma) and SREBP1c (sterol regulatory element-binding protein 1c).
• AN and PT effectively blocked the surge of reactive oxygen species (ROS) during adipocyte differentiation.

Conclusions:

• Andrographolide and pterostilbene demonstrate significant anti-adipogenic activity through distinct molecular pathways.
• These phytocompounds inhibit adipogenesis by modulating miR27a, SIRT1, and crucial transcription factors (PPARγ, SREBP1c), and by reducing ROS.
• The findings provide a molecular basis for the potential therapeutic use of AN and PT in managing obesity and related metabolic disorders.